BCAB

BioAtla, Inc.

1.71 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

BioAtla, Inc. stock is down -33.72% since 30 days ago. The next earnings date is Jul 30, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 3 May’s closed higher than April. In the last 5 Unusual Options Trades, there were 4 CALLs, 1 PUT. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
16 Apr 19:48 19 Jul, 2024 2.50 CALL 500 2848
25 Apr 16:07 19 Jul, 2024 2.50 CALL 425 3360
23 May 14:55 19 Jul, 2024 2.50 CALL 1999 4234
23 May 17:11 19 Jul, 2024 2.50 CALL 1176 4234
24 May 14:09 21 Jun, 2024 2.50 PUT 500 894

About BioAtla, Inc.

BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate.

  • JP Morgan
    Thu May 23, 12:08
    buy
    confirm
  • HC Wainwright & Co.
    Wed May 15, 11:18
    buy
    confirm